This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novo Nordisk A/s. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Bo Falck Hansen: Innovator in Insulin Analogues
Introduction
Bo Falck Hansen is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin analogues. His work focuses on addressing critical medical conditions such as diabetes, obesity, and cardiovascular diseases.
Latest Patents
Hansen holds a patent for "Acylated insulin analogues and uses thereof." This invention relates to novel insulin analogues and derivatives, specifically acylated insulin analogues, and their pharmaceutical applications. The patent emphasizes the importance of these analogues in the treatment and prevention of various medical conditions.
Career Highlights
Bo Falck Hansen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at Novo Nordisk has allowed him to contribute to groundbreaking research and development in the field of insulin therapies.
Collaborations
Hansen has collaborated with notable colleagues, including Grith Skytte Olsen and Lauge Schaeffer. These partnerships have fostered innovation and enhanced the development of effective treatments in the pharmaceutical industry.
Conclusion
Bo Falck Hansen's work in the field of insulin analogues showcases his dedication to improving healthcare outcomes for individuals with diabetes and related conditions. His contributions continue to influence the pharmaceutical landscape significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile